Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms

被引：0
|
作者：
E. Bugianesi
A. Gastaldelli
E. Vanni
R. Gambino
M. Cassader
S. Baldi
V. Ponti
G. Pagano
E. Ferrannini
M. Rizzetto
机构：
[1] University of Turin,Division of Gastro
[2] University of Pisa,hepatology, San Giovanni Battista Hospital
[3] University of Turin,Metabolism Unit, C.N.R. Institute of Clinical Physiology and Department of Internal Medicine
[4] Università di Torino,Department of Internal Medicine, San Giovanni Battista Hospital
来源：
Diabetologia | 2005年 / 48卷
关键词：
Fatty liver; Glucose disposal; Glucose production; Glycerol appearance; Lipoperoxidation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：634 / 642
页数：8
相关论文
共 50 条
  • [31] INSULIN RESISTANCE AS A RISK FACTOR FOR HYPERTENSIVE PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
    Latea, L.
    Negrea, S.
    JOURNAL OF HYPERTENSION, 2010, 28 : E410 - E410
  • [32] Insulin Resistance as a Risk Factor for Hypertensive Patients with Non-Alcoholic Fatty Liver Disease
    Latea, Luminita
    Negrea, Stefania
    AUSTRALASIAN MEDICAL JOURNAL, 2010, 3 (01): : 10 - 13
  • [33] Beneficial effect of omarigliptin on diabetic patients with non-alcoholic fatty liver disease/non-alcoholic steatohepatitis
    Sachiko Hattori
    Kazuomi Nomoto
    Tomohiko Suzuki
    Seishu Hayashi
    Diabetology & Metabolic Syndrome, 13
  • [34] Beneficial effect of omarigliptin on diabetic patients with non-alcoholic fatty liver disease/non-alcoholic steatohepatitis
    Hattori, Sachiko
    Nomoto, Kazuomi
    Suzuki, Tomohiko
    Hayashi, Seishu
    DIABETOLOGY & METABOLIC SYNDROME, 2021, 13 (01):
  • [35] Relationship between glucagon like peptide-1 and non-alcoholic fatty liver disease in diabetic and non-diabetic patients
    Sheriba, Nermin
    Samy, Merhan
    Adel, Caroline
    Anas, Samaa
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (01) : 526 - 529
  • [36] Fatty liver biomarkers and insulin resistance indices in the prediction of non-alcoholic fatty liver disease in Ghanaian patients
    Bockarie, A. S.
    Nartey, Y. A.
    Nsiah, P.
    Edzie, E. K. M.
    Tuoyire, D.
    Acquah, S.
    Eliason, S.
    Nkum, B.
    ENDOCRINOLOGY DIABETES & METABOLISM, 2023, 6 (06)
  • [37] Prevalence of non-alcoholic fatty liver disease among patients with non-diabetic chronic kidney disease detected by transient elastography
    Maha Abdelmoneim Behairy
    Ahmed Fouad Sherief
    Hany Aly Hussein
    International Urology and Nephrology, 2021, 53 : 2593 - 2601
  • [38] Prevalence of non-alcoholic fatty liver disease among patients with non-diabetic chronic kidney disease detected by transient elastography
    Behairy, Maha Abdelmoneim
    Sherief, Ahmed Fouad
    Hussein, Hany Aly
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2021, 53 (12) : 2593 - 2601
  • [39] Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in patients with HIV
    Verna, Elizabeth C.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2017, 2 (03): : 211 - 223
  • [40] HOMA-IR is an effective biomarker of non-alcoholic fatty liver disease in non-diabetic population
    Zeng, Pei
    Cai, Xiangsheng
    Yu, Xiaozhou
    Huang, Lu
    Chen, Xi
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2023, 51 (10)
12345